Artificial intelligence is dramatically speeding up drug development — and a proprietary survey shows how it's priming a ...

Artificial intelligence is rapidly transforming the pharmaceutical industry, dramatically reducing the time and cost required to develop new medicines before they ever reach human testing, according ...

Clinical research has transformed childhood cancer survival in the past 50 years. Cooperative group trials have tailored therapy according to risk stratification, with overall survival across all ...

July 16 (Reuters) - Prediction market platform Kalshi will start taking bets on the outcomes of clinical trials and FDA ...

July 17 (Reuters) - GSK will halt development of its experimental drug to treat refractory chronic cough after the therapy ...

A drug already safe for humans reduces disease-linked early features of Alzheimer’s in a lab model of the disease, say ...

Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted ...

Drug companies have quietly stepped back from development programs in long COVID and related conditions, leaving patients ...

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines ...

Move comes as prediction platforms rapidly gain popularity and offer opportunities to bet on virtually anything ...

The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...

The study failure costs Agios a chance to one-up Novo Nordisk and represents yet another setback in a disease that’s ...